Angiotensin‐(1‐7) Inhibits Angiotensin II Intra‐neuronal Signaling

Rui-Fang Yang,Jing-Xiang Yin,Yu-Long Li,Harold D. Schultz,Matthew C. Zimmerman
DOI: https://doi.org/10.1096/fasebj.24.1_supplement.1051.12
2010-01-01
The FASEB Journal
Abstract:Elevated levels of superoxide (O2•−) induced by angiotensin II (AngII) play a vital role in the sympathoexcitation associated with many neuro‐cardiovascular diseases, such as hypertension and heart failure. Recent studies report that angiotensin‐(1‐7) [Ang‐(1‐7)] increases neuronal levels of nitric oxide (NO•), which can rapidly react with O2•− to limit its potential signaling. We hypothesized that Ang‐(1‐7) inhibits AngII intra‐neuronal signaling by modulating O2•− levels. Using differentiated CATH.a neurons, we observed that the AngII (100 nM)‐induced increase in O2•−, as measured by EPR spectroscopy and DHE fluorescence, was markedly attenuated by pretreatment with 100 nM Ang‐(1‐7) (EPR arbitrary units/103 neurons: vehicle = 938 ± 67; AngII = 1310 ± 92*; Ang‐(1‐7) + AngII = 1004 ± 95; *P<0.05 vs. vehicle and Ang‐(1‐7) + AngII). This inhibition was blocked by the Ang‐(1‐7) receptor antagonist A‐779 (1261 ± 107; P<0.05 vs. Ang‐(1‐7) + AngII). Further, AngII‐induced inhibition of neuronal K+ current (IKv; 49 ± 9% inhibition) was attenuated by Ang‐(1‐7) (22 ± 4% inhibition; P<0.05 vs. AngII alone). These findings indicate that Ang‐(1‐7) attenuates the AngII‐induced increase in O2•− and inhibition of IKv. Ang‐(1‐7) signaling in neurons may play an important protective role counterbalancing AngII sympathoexcitation in the pathogenesis of cardiovascular diseases. NIH P20RR017675 and P01HL062222
What problem does this paper attempt to address?